Platforms for enzymatic assays for biomarkers, including systems, methods, and measuring devices by which a biomarker, such as creatinine, is measured using a small amount of biological fluid, such as blood, plasma, or serum. The measuring device or biosensor can be a test strip including a layered active component assembly positioned between two outer layers which enables multi-step enzymatic reactions operating in kinetic and/or endpoint (in which the reaction is allowed to near completion), and generally includes multiple layers with primary enzyme(s), coupling enzyme(s), and reagents to produce an optical signal correlated to the concentration of a biomarker in the sample. The test strip can be read using a portable optical reader coupled to a smart phone or tablet.

Platforms for enzymatic assays for biomarkers, including systems, methods, and measuring devices by which a biomarker, such as creatinine, is measured using a small amount of biological fluid, such as blood, plasma, or serum. The measuring device or biosensor can be a test strip including a layered active component assembly positioned between two outer layers which enables multi-step enzymatic reactions operating in kinetic and/or endpoint (in which the reaction is allowed to near completion), and generally includes multiple layers with primary enzyme(s), coupling enzyme(s), and reagents to produce an optical signal correlated to the concentration of a biomarker in the sample. The test strip can be read using a portable optical reader coupled to a smart phone or tablet.

A heart failure marker that is simple, and preferably usable by non-invasive test. A method for measuring heart failure risk, comprising: (A) measuring an angiotensinogen amount value of urine collected from a subject.

A heart failure marker that is simple, and preferably usable by non-invasive test. A method for measuring heart failure risk, comprising: (A) measuring an angiotensinogen amount value of urine collected from a subject.

The present invention provides a detection device comprises a testing element and a transparent area, wherein the testing element comprises a detection area which is configured to detect a presence of an analyte in a liquid sample; the transparent area is configured to read the test result on the detection area through the transparent area; a part of the transparent area contacts a part of the detection area, or the detection area and the transparent area are arranged in one sealed space, thus to make the air in the sealed space not exchange with the air outside the sealed space; the scheme can reduce the mist to ensure the test result is displayed clearly.

An exemplary urinalysis device for non-clinical use is described as having: a housing; a touchscreen on the housing; a test strip holder, which is removably, slidably engaged with the housing; at least two light emitting diode (LED) light sources, housed in the housing and including a white LED and a red-blue-green (RBG) LED; a camera module housed in the housing, both the plurality of LEDs and the camera module directed to an illumination and detection zone; a timer system; and/or a computational system in electronic communication with the plurality of LEDs, the camera module and the timer system, the computational system including a processor and a memory. Related methods and systems also are described.

An exemplary urinalysis device for non-clinical use is described as having: a housing; a touchscreen on the housing; a test strip holder, which is removably, slidably engaged with the housing; at least two light emitting diode (LED) light sources, housed in the housing and including a white LED and a red-blue-green (RBG) LED; a camera module housed in the housing, both the plurality of LEDs and the camera module directed to an illumination and detection zone; a timer system; and/or a computational system in electronic communication with the plurality of LEDs, the camera module and the timer system, the computational system including a processor and a memory. Related methods and systems also are described.

To reduce the effect of L-proline in the reaction of a sarcosine oxidase. A modified sarcosine oxidase having reduced reactivity to L-proline is provided.

To reduce the effect of L-proline in the reaction of a sarcosine oxidase. A modified sarcosine oxidase having reduced reactivity to L-proline is provided.

A biometric system is disclosed. The biometric system comprises: a measurement cartridge; and a meter, equipped with the measurement cartridge, for measuring an analyte present in a sample of the measurement cartridge. The measurement cartridge comprises a reagent container, a capillary module, and a reagent rod. The reagent container receives a liquid reagent and has a top sealed with a sealing film. The capillary module comprises a capillary tube which is located on an upper side of the reagent container and collects the sample by a capillary phenomenon, and the capillary tube is introduced into the reagent container by rupturing a contact portion to the sealing film by an applied pressure. The reagent rod comprises a plurality of dry reagent accommodating portions which are located on an upper side of the reagent container and accommodate a drying reagent, and the reagent rod is introduced into the reagent container by rupturing a contact portion to the sealing film by an applied pressure.